Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

Early physical rehabilitation therapy between 24 and 48 h following acute ischemic stroke onset: a randomized controlled trial [with consumer summary]
Wang F, Zhang S, Zhou F, Zhao M, Zhao H
Disability and Rehabilitation 2022;44(15)::3967-3972
clinical trial
7/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: Yes; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: Yes; Adequate follow-up: Yes; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed*

PURPOSE: Early mobilization is believed to be helpful for patients with acute ischemic stroke. This study aimed to compare the difference between starting rehabilitation between 24 and 48 h and 72 and 96 h following the onset of ischemic stroke. MATERIALS AND METHODS: This was a single-center, single-blind, randomized controlled trial. The early rehabilitation (ER) group started exercising between 24 and 48 h after stroke onset, which the standard rehabilitation (SR) group started exercising between 72 and 96 h. The two groups received sitting, standing, and repetitive body strength training respectively. RESULTS: In this study, 110 patients were analyzed. Patients in the early rehabilitation group had more favorable outcomes (the modified Rankin Scale score 0 to 2, ER group 32 versus SR group 20, adjusted odds ratio 2.27, 95% CI 1.05 to 4.87; p = 0.036) at 3-month follow-up. The simplified Fugl-Meyer assessment (FMA) scores for the lower extremity were influenced by the interaction effect (F = 7.24, p = 0.01). The post-hoc analysis revealed a difference in the lower extremity FMA score at one week after stroke (difference 2.30 (95% CI 0.65 to 3.96); p = 0.007). CONCLUSIONS: Early physical rehabilitation training between 24 and 48 h may be beneficial and improve patients' lower extremity function within the first week. CLINICAL TRIAL REGISTRATION UNIQUE IDENTIFIER: NCT02718534.

Full text (sometimes free) may be available at these link(s):      help